skip to main content

Research Programs & Priorities

Each component of Texas A&M Health has a research office that is responsible for local administration of its research programs and an associate dean (or equivalent) who reports to the Vice President for Research. Each component also has a number of signature research programs and priorities.

College of

Larry Bellinger, PhD
Associate Dean for Advanced Education

Signature programs and priorities:

  • Tooth development and genetics
  • Dentin, bone and cartilage matrix biology
  • Temporomandibular joint function, dysfunction and pain
  • Implants, bone regeneration devices and devices to move teeth
  • Stem cell applications for regenerative strategies and scaffold design
  • Use of biomarkers to detect oral cancer

College of

Hubert Amrein, PhD
Senior Associate Dean of Research

Research priorities:

  • Brain, Behavior, Psychiatric and Neurological Disorders
  • Biomedical Engineering and Regenerative Medicine
  • Cancer, Cell and Developmental Biology
  • Cardiovascular, Lymphatic and Metabolic Disease
  • Genetics, Genomics and Networking Biology
  • Infection, Immunity and Inflammation

College of

Jane N. Bolin, PhD, JD, RN
Associate Dean for Research

Signature programs and priorities:

  • Forensic nursing
  • Hispanic populations
  • Childhood obesity
  • Public health nursing
  • Chronic diseases
  • Vulnerable populations

Irma Lerma Rangel
College of Pharmacy

Mansoor Khan, PhD
Vice Dean of College Station Campus
Interim Department Head of Pharmaceutical Sciences

Signature programs and priorities:

  • Drug Delivery and formulations, including nanoparticulates
  • Pharmacokinetics and bioequivalence studies
  • Support for Investigational New Drugs (INDs), New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs for generic products)
  • Use pharmacological and genetic approaches to inform on biology
  • Integrate engineering, biological, medicinal chemistry and formulation/delivery in drug discovery programs focused on defined diseases where we have existing strengths
  • Establish an integrated research facility for drug discovery, development and delivery, underpinned by a pharmaceutical focus in pharmacology, integrative biology, immunology and microbiology
  • Drug repositioning
  • Pediatric products
  • Post marketing product evaluations

School of
Public Health

Tiffany Radcliff, PhD
Associate Dean for Research

Signature programs and priorities:

  • Prevention research
  • Healthy aging through long-term care issues
  • Environmental exposures and adverse pregnancy outcomes

Institute of
Biosciences and Technology

Peter J. A. Davies, MD, PhD
Associate Director

Signature programs and priorities:

  • Cancer and stem cell biology
  • Environmental and genetic medicine
  • Infectious and inflammatory diseases
  • Translational cancer research